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The influence of gender and aortic aneurysm size
on eligibility for endovascular abdominal aortic
aneurysm repair
Matthew P. Sweet, MD,b Mark F. Fillinger, MD,b Tina M. Morrison, PhD,a and
Dorothy Abel, BSME,a Lebanon, NH; and Rockville, Md
Objectives: The purpose of this study was to compare the eligibility of men and women with infrarenal abdominal aortic
aneurysms (AAAs) for on-label endovascular aneurysm repair (EVAR) as part of the clinician-Food & Drug Adminis-
tration (FDA) collaborative effort, the Characterization of Human Aortic Anatomy Project (CHAP).
Methods:Computed tomography (CT) scanswith 3D reconstruction from a single institution obtained between July 1996 and
December 2009, including standardized measurements by a blinded third-party (M2S, West Lebanon, NH) were examined.
For inclusion, abdominal aortic aneurysm (AAA) had to be infrarenal, unrepaired, and >5 cm, or 4 cm to 5 cm if the
orthogonal sac diameter was more than twice the aortic diameter at the renal level. Scans were included regardless of
subsequent EVAR, open repair, or lack of treatment. One thousand sixty-three unique, unrepaired AAAs were analyzed.
Results: Neck length, diameter, and angulation differ for women (P < .001) even after adjustment for patient age and AAA
size. EVAR eligibility based on device Instructions for Use (IFU) criterion is affected by gender. Neck length <15 mm was
found in 47% ofmen and 63% of women. Neck angulation exceeding 60 degrees was found in 12% ofmen and 26% of women.
Minimum iliac diameter of 6 mmwas found in 35% of men and 55% of women. Only 32% of men and 12% of women met all
three neck criterion and had iliac lumen diameters >6 mm. Logistic regression modeling shows that older patient age (odds
ratio [OR], 0.84 per decade), increased aneurysm diameter (OR, 0.70 per cm), and female gender (OR, 0.4) are each
independently associated with decreased odds of meeting all device IFU neck criterion (P < .05). EVAR eligibility by neck
criterion does not decline significantly until AAA size exceeds 5.5 cm in women and 6.5 cm in men.
Conclusion:Women are significantly less likely to meet device IFU criterion for EVAR. Aortic neck criteria and iliac access
are important for men and women, but more women than men fail to meet IFU criterion. Devices that accommodate
shorter infrarenal AAA neck length will have the greatest impact on expanding on-label EVAR regardless of gender.
Lower profile devices and those that accommodate higher neck angulation are expected to expand EVAR eligibility
further for women. EVAR eligibility is unlikely to be lost as AAAs enlarge to 5.5 cm in women and 6.5 cm in men.
Observation of small AAAs until they reach the standard threshold size for repair should not compromise EVAR
eligibility. ( J Vasc Surg 2011;54:931-7.)
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gTwo large randomized control trials of endovascular vs
open repair of abdominal aortic aneurysm (AAA) have shown
that periprocedural mortality is significantly reduced with
endovascular aneurysm repair (EVAR).1,2 Women were un-
der-represented in these trials, comprising only 9% of the
study populations. Similarly, clinical trials of EVAR devices
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doi:10.1016/j.jvs.2011.02.054ith current United States Food & Drug Administration
FDA) approval contained 6% to 13% women,3-7 despite data
ndicating that 21% of AAAs occur in women in the United
tates.8 In both the randomized and pivotal trials, strict ana-
omic enrollment criterion may have reduced the number of
emale patients. Data from the National Inpatient Sample
evealed that women undergoing elective AAA repair are less
ikely to be treated with EVAR than are men.9 A review of the
ational Surgical Quality Improvement Program (NSQIP)
atabase revealed that women had higher perioperative mor-
idity and mortality after EVAR despite adjustment for nu-
erous clinical covariates.10 Furthermore, several reports of
mall cohorts from individual centers have reported that
omen treated with EVAR had shorter, more angulated
nfrarenal necks as well as small iliac arteries, resulting in an
ncreased incidence of treatment with EVAR outside the
evice’s Instructions for Use (IFU).11-13 These studies sug-
est that anatomic features are an important reason for the
ecreased use and worse outcomes of EVAR in women. The
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October 2011932 Sweet et alanatomic data in these studies, however, are limited by signif-
icant selection bias. Detailed, adjusted anatomic data from
population-based samples are needed tobetter understand the
differences in AAA anatomy and EVAR eligibility between
men and women. Ultimately, such data may better inform
future stent graft design, testing, and evaluation; increase the
percentage of patients who are candidates for EVAR; and
improve device efficacy.
The Characterization of Human Aortic Anatomy Proj-
ect (CHAP) is a collaboration of clinicians and the FDA
with a goal to better characterize aortic anatomy in the
context of endovascular aortic devices. This study is the first
of a series examining aortic anatomy as it relates to current
and future endovascular device development.
The purpose of this study was to quantitatively describe
the differences in AAA morphology between men and
women in a large case series using anatomic measurements
by blinded observers with high quality three-dimensional
(3-D) computed tomography (CT) imaging. Specifically,
anatomic characteristics between men and women were
compared with respect to criterion in the IFU for FDA-
approved devices to determine the relationship between
gender and the potential for on-label use of EVAR. An
additional specific purpose was to assess the relationship
between gender, IFU eligibility, and AAA size, as it has
been suggested that observation of small AAAs in men and
women reduces the likelihood of successful EVAR.
PATIENTS AND METHODS
This study was conducted under approval by the local
Institutional Review Board (Committee for Protection of
Human Subjects). We obtained the complete dataset of all
CT scans with 3-D reconstructions for AAAs between 1997
and 2009 at Dartmouth Hitchcock Medical Center
(DHMC). CT angiograms to assess AAAs were prospec-
tively submitted for 3-D reconstruction and analysis by
blinded third party observers (M2S, West Lebanon, NH).
For the large majority of this period, all scans evaluating
AAAs were routinely submitted for 3-D reconstruction if
there was a consideration of open or endovascular repair.
DHMC serves as both a primary care hospital for the
local area as well as a tertiary referral center for the sur-
rounding northern New England region. Approximately
65% of patients referred to the Section of Vascular Surgery
come from our local area and 35% are referred by general or
vascular surgeons in the outlying communities for tertiary
care. This creates a case mix enriched with complex referral
cases, but dominated by population-based characteristics.
This dataset will act as a reference for future multicenter
analysis within the scope of CHAP.
Reconstructions and measurements were obtained by a
trained technician blinded to the proposed treatment using
proprietary software. Technicians are monitored with ac-
ceptance criteria of variation between measurers (interob-
server variability) of 2 mm for aortic and iliac diameters, 3
mm for maximal sac diameter, 5 mm for long centerline
lengths (over 10 cm), 3 mm for apposition lengths, and 10
degrees for angles (M2S personal communication). These tanges are equivalent or superior to published interobserver
ariability for clinicians.14
Each CT scan was reviewed for a prespecified set of 23
natomic measurements initially determined in conjunction
ith the Society for Vascular Surgery reporting standards15-19
nd the FDA/Center for Devices and Radiological Health),
hich is publicly available (http://www.m2s.com).Diameter
easurements aremadeorthogonal to the center line access of
he vessel and extend from the outer wall to outer wall. The
nfrarenal neck is defined by the orthogonal CT cross section
mmediately distal to the lowest lying renal artery measuring
3mmand, by definition, continues until the aortic diameter
hanges by10%. Accessory renal arteries smaller than 3mm
ere notmeasured. Themaximal aortic neck diameterwas the
argest diameter within the first 15mmor within the available
roximal seal zone, whichever was shorter (ie, for a 10-mm
ong neck, the maximum aortic neck diameter had to be
ithin the first 10 mm beyond the lowest renal artery). Infra-
enal neck angulation is the angle between the longitudinal
xis of the infrarenal neck and the body of the AAA defined
rom the end of the neck to the aortic bifurcation.15,16,20
ortuosity index is a ratio of the centerline to straight line
istance between the lowest lying renal artery and the ipsilat-
ral femoral bifurcation reported as a percentage increase.15,16
he minimal lumen diameter of the external iliac artery was
sed for assessment of adequacy of iliac access.
The analysis began with the complete dataset of measure-
ents from CTs with 3-D reconstruction of the aorta from
HMC. All scans identified as being postoperative or of
horacic aneurysms were excluded, reducing the number
vailable for analysis from 6767 to 2566. Due to M2S cate-
orization methods, the remaining dataset included patients
ith thoracoabdominal aortic aneurysms, as well as patients
ith a primarily thoracic aortic aneurysm but also a concom-
tant AAA. To eliminate these patients, we subsequently ex-
luded all cases of aneurysm involving the aorta at the renal
evel (defined as having an aortic diameter 40 mm at the
enal orifices), aneurysms with a maximal aortic diameter 4
m, and AAAs with maximal diameter between 4 and 5 cm if
he maximal size was less than twice the diameter of the
ormal aorta at the renal artery level. This identified patients
eing evaluated for repair and those thatmight be expected to
ave repair within a few years. For AAAs with multiple 3-D
atasets, we then identified and retained only the most recent
can before any intervention, if an intervention had occurred.
Before multicenter data analysis in CHAP, a limited
umber of single center analyses will be performed in order
o test the analytical methods on a dataset that can be
nblinded if necessary (eg, to evaluate outliers). To evalu-
te the mathematical “filter” criteria that may ultimately be
sed in a fully blinded multicenter CHAP dataset, CT scans
or all 140 patients with infrarenal neck diameter 30 to 40
m were individually reviewed. Seventy-four (53%) were
xcluded (53 suprarenal aneurysms, 9 with prior open
epair, 12 due to incomplete data). The remaining 66
atients were included in the final analysis. A similar review
as performed on a random sample of 80 CT scans. Of
hese 80, only two patients’ (2.5%) scans were excluded,
o
i
a
c
c
d
a
g
m
f
s
A
a
7
l
o
1
A
i
a
a
w
m
e
w
b
a
p
t
e
i
s
w
t
a
s
E
c
c
t
o
f
(
5
e
o
c
A
5
s
c
f
i
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 4 Sweet et al 933one patient had a prior open AAA repair with proximal
aneurysmal degeneration, and one patient had a suprarenal
aneurysm. After all exclusion criterions had been used,
1063 unique, unrepaired AAAs remained for analysis.
This selection process was intended to identify consecu-
tive cases of infrarenal AAA (normal aorta at the renal level)
with a complete set of measurements, whether patients were
ultimately selected for open repair, EVAR, or observation.
Instructions for use vary for different commercial en-
dografts. The common IFU criterion of all four commer-
cially available bifurcated endovascular stent grafts were
used: an infrarenal neck diameter of 18 to 32 mm, infrare-
nal neck length of at least 15 mm, infrarenal neck angula-
tion of60 degrees, and iliac access lumen of at least 6mm.
Iliac tortuosity and calcification are not accounted for in
this analysis of iliac accessibility. Iliac artery aneurysm was
defined as a common iliac diameter exceeding 20 mm.
Statistical analysis was performed using Stata (Stata V
9.2, Statacorp, College Station, Tex). Descriptive statistics
of median and interquartile ranges (25th and 75th percen-
tiles) are reported. Comparisons among AAA size catego-
ries were made using analysis of variance. Comparisons
between continuous variables were made using t test and
adjusted comparisons used linear regression modeling. Lo-
gistic regression models were used to perform adjusted
comparisons of nominal variables.
RESULTS
The patient cohort is described in Table I. This unad-
justed analysis demonstrates that women with AAAs have
shorter and more angulated infrarenal aortic necks, more
angulated suprarenal aortas, and smaller iliac arteries. Pa-
tient age and AAA size are also thought to affect aortic
diameter and overall morphology, so these factors were
taken into account in the analysis. Even after adjustment for
patient age and AAA size, the mean AAA neck in the female
cohort was 3.4 mm (95% confidence interval [CI], 1.5-5.2)
shorter in length, 1.3 mm (95% CI, 0.7-1.8) narrower in
diameter, and 8.6 degrees (95% CI, 6.2-10.9) more angu-
lated than in the male cohort (P .001 for each measure).
The median measures of AAA neck anatomy by AAA size
Table I. Patient cohort data (mean  SD)
Men Women P value
Number (%) 812 (76) 251 (24)
Age (years) 74  9 77  8  .0001
Maximum sac
diameter (mm) 59  12 58  10 .15
Neck diameter (mm) 25  4 24  4  .0001
Neck length (mm) 19  12 15  12  .0001
Infrarenal neck angle
(degrees) 40  16 48  18  .0001
Suprarenal aortic
angle (degrees) 20  13 28  19  .0001
External iliac artery
diameter (mm) 7.0  1.6 5.6  1.3  .0001are reported in Table II. tMultivariate logistic regression modeling shows that
lder patient age (odds ratio [OR], 0.84 per decade),
ncreased maximal aneurysm diameter (OR, 0.70 per cm),
nd female gender (OR, 0.4) are each independently asso-
iated with decreased odds of meeting all three device IFU
riterion for the aortic neck (P  .05 for age, gender, and
iameter). The percentages of patients who met each IFU
natomic criterion are listed by gender and AAA size cate-
ory in Table III. A short infrarenal neck length was the
ost likely reason to exclude a patient of either gender
rom meeting IFU criterion. Small iliac access was the
econd most common reason followed by neck angulation.
fter exclusion of suprarenal AAA, neck diameter was rarely
cause for exclusion for EVAR of infrarenal AAA.
Bilateral iliac luminal diameters 6 mm were seen in
0% of men and 38% of women. Bilateral minimum iliac
umen diameters6 mmwere seen in 17% of men and 47%
f women (Table IV). Among men, 13% had unilateral and
7% had bilateral iliac artery lumens smaller than 6 mm.
mong women, 15% had unilateral and 47% had bilateral
liac lumens smaller than 6 mm in diameter. Unilateral iliac
rteries over 20 mm were seen in 2% of women and men,
nd bilateral iliac arteries 20 mm were seen in 5% of
omen and 7% of men. These would likely not exclude
ost patients, but would rather infer extension into the
xternal iliac artery for sealing. Only 32% ofmen and 12% of
omen met all three infrarenal neck criterion and had
ilateral iliac artery lumen diameters over 6 mm.
Fig 1 demonstrates the decline in EVAR eligibility
ccording to neck anatomy with increasing AAA size by
atient gender. The change was statistically significant by a
est of trend (P  .01). The largest drop-off in EVAR
ligibility by neck anatomic criterion occurs above 5.5 cm
n women and 6.5 cm in men. These changes in eligibility
eem to be driven by neck length and angulation. Among
omen, 22% lose eligibility due to angulation and 13% due
o neck length as they exceed the 5.5 cm threshold. Iliac
ccess diameter and aortic neck diameter do not change
ignificantly beyond the 5.5 cm threshold.
Sensitivity analyses describe the expected gains in
VAR eligibility with adjustment of a single IFU anatomic
riterion while holding the other anatomic criteria at their
urrent threshold. These comparisons reveal that reducing
he criteria for neck length to 7.5 mm while leaving the
ther criteria unchanged will increase EVAR eligibility
rom 46% to 70% in men and from 25% to 45% in women
Fig 2). Decreasing delivery system profiles to fit through
.5 mm (17F outer diameter) iliac access bilaterally would
nable device delivery in 50% of women without a conduit
r other type of dilation, assuming neck anatomy were held
onstant (Fig 3). Increased tolerance of a 90 degree neck to
AA angle would increase eligibility of men from 46% to
1%, and would increase women from 25% to 32%. While
mall in absolute terms, this would be a 28% relative in-
rease in EVAR eligibility. Aneurysms with angulated necks
requently had concomitant short proximal seal zones, so
ncreases in tolerance of neck angulation without improved
olerance of short proximal seal length does not change
a
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considering the angulation parameter alone.
DISCUSSION
This is the largest study to date of aorto-iliac anatomy
Table II. Median neck measurements (IQR) by gender an
M
4-5 cm (n  147) 5-5.5 cm (n
Neck length (mm)
Men 16 (10-28) 19 (10-
Women 12 (8-26) 15 (6-2
Neck diameter (mm)
Men 26 (24-28) 24 (22-
Women 25 (24-27) 23 (20-
Neck angulation (degrees)
Men 33 (23-41) 36 (28-
Women 32 (23-43) 41 (30-
AAA, Abdominal aortic aneurysm; IQR, interquartile range.
Table III. Percentage of patients meeting IFU neck criter
Ma
4-5 cm 5-5.5
Neck length 15 mm
Men 55 59
Women 36 48
Neck diameter 18-32 mm
Men 96 97
Women 100 90
Neck angulation 60 degrees
Men 97 92
Women 94 89
Meet all three neck criterion
Men 52 54
Women 36 37
AAA, Abdominal aortic aneurysm; IFU, Instructions for Use.
Table IV. Iliac artery measurements by gender and AAA s
M
4-5 cm 5-
Bilateral iliac diameter 6 mm (%)
Men 15
Women 42
Either iliac diameter 20 mm (%)
Men 19
Women 15
Bilateral iliac diameters 6-20 mm (%)
Men 68
Women 45
Mean tortuosity index (%)
Men 23
Women 22
AAA, Abdominal aortic aneurysm.
By analysis of variance, P values are not statistically significant.in a consecutive series of patients with abdominal aortic aneurysms. Notably, the series includes patients that had
pen repair or observation, as well as EVAR, so as not to
ias the anatomic evaluation. This study shows that infra-
enal aorto-iliac anatomy in women differs significantly
rom that of men, even when controlling for age and
A size category
l aneurysm diameter
P value7) 5.5-6.5 cm (n  382) 6.5 cm (n  217)
17 (9-27) 11 (6-21) .001
10 (6-20) 7 (4-22) .12
25 (22-27) 26 (23-29) .28
24 (21-26) 23 (22-28) .87
37 (28-50) 49 (33-61) .001
53 (42-62) 61 (48-73) .001
y patient gender and AAA size category
l aneurysm diameter
Entire cohort5.5-6.5 cm 6.5 cm
57 38 53
35 30 37
96 91 95
89 83 90
89 75 88
67 45 74
48 29 46
19 5 25
ategory
al aneurysm diameter
Overall cohortm 5.5-6.5 cm 6.5 cm
23 17 19
49 55 51
19 25 20
5 15 10
61 60 64
45 33 42
25 30 27
27 33 26d AA
axima
 31
30)
3)
26)
26)
46)
53)ion b
xima
cmize c
axim
5.5 c
17
54
17
10
68
41
23
23neurysm size. Our analysis confirms the finding that
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Volume 54, Number 4 Sweet et al 935women are much less likely than men to meet device IFU
criterion for current endovascular devices due to decreased
neck length, increased neck angulation, and small iliac
Fig 1. Percentage of patients by gender who meet all three neck
Instructions for Use (IFU) by maximal abdominal aortic aneurysm
(AAA) sac diameter (P  .01 by test of trend).
Fig 2. Percentage of patients who would meet Instructions for
Use (IFU) criterion as mandatory neck length is shortened, hold-
ing other neck IFU criterion constant.
Fig 3. Percentage of patients with bilateral iliac diameters above
given diameter.access. These anatomic differences exclude a substantial tajority of women from meeting current device IFU ana-
omic criterion.
In one of the first reports of EVAR eligibility by patient
ender, Velasquez et al21 reported that among the 19
omen studied, only 7 met IFU criterion for early gener-
tion devices. Another early large single center report dem-
nstrated that among the 29 women treated with EVAR,
he necks were narrower and shorter and the iliac diameters
ere smaller.12 The initial trial data with the Zenith device
Cook, Inc, Bloomington, Ind) demonstrated that women
ere more likely to have small iliac arteries and angulated
nfrarenal necks.11 A large single center experience re-
orted that women were more often treated outside IFU
riterion due to neck length (7.1% vs 1.3%) and angulation
3.5% vs 0.7%).13 A review of the NSQIP database revealed
hat women had higher perioperative morbidity (17.8% vs
0.6%; P  .001) and mortality (3.4% vs 2.1%; P  .014)
espite adjustment for numerous clinical covariates, and
he authors speculated that this was related to anatomic
ifferences, noting a higher incidence of iliac conduits and
rachial access in women (2.8% vs 1.0%; P .009).10 Abedi
t al10 did not have access to detailed anatomic information
o confirm this hypothesis. Our results corroborate findings
hat suggest significantly different anatomy in women, and
t differs with the findings of two early reports that suggest
atient gender did not affect EVAR eligibility.22,23 This
tudy represents the first large case series, including consec-
tively enrolled unrepaired aneurysms to corroborate the
forementioned findings and hypotheses. We feel it is im-
ortant that the measurements were performed prospec-
ively by a blinded third party using high quality 3-D
econstructions and standardized measurements, with no
ias to try to fit the anatomy into the inclusion criterion.
atients who had observation and open repair are included
n an effort to reflect all patients with aneurysms rather than
selected EVAR subset. Our study population appears to
eflect the U.S. population prevalence of AAA, as 24% of
he patients in this study are women, similar to the 21%
ound in a nationwide AAA screening study.8 These data,
herefore, should more accurately reflect true anatomic
ifferences for AAA in women, without the biases of pre-
election for EVAR. Furthermore, this study quantitates
he influence of neck angulation and iliac access on EVAR
ligibility among women and provides estimates of gains in
ligibility if newer devices were constructed with different
FU criterion.
It is important to distinguish between the IFU criterion
or neck and iliac anatomy. Adverse iliac anatomy, although
otentially hazardous, is often amenable to adjunctive tech-
iques (such as iliac conduits or aorto-uni-iliac devices) that
ill enable EVAR to be performed safely and effectively.
onversely, hostile neck anatomy has been associated with
dverse outcome in a number of studies.24,25 Although
any patients are currently being successfully treated out-
ide IFU criterion, the outcome of such use is less well
haracterized.26 It is not appropriate to assume that the
esults of large randomized trials will apply to patients
reated outside the IFU, as the large trials to date have not
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October 2011936 Sweet et alhad a percentage of women that correlates with the preva-
lence in the population or even the percentage repaired in
national databases. The performance characteristics of
these devices have not been adequately tested and reported
outside of the IFU criterion, and, therefore, we lack data to
precisely predict their performance in these conditions.
Given the early-term benefits inmorbidity andmortality for
EVAR, clinicians are left with a difficult choice in patients
who are not good candidates for open repair yet do not fully
meet the IFU criterion for currently available devices. This
is especially true for womenwho have higher mortality rates
than men with both EVAR and open repair, and a threefold
higher risk of rupture while under surveillance.27,28 Giles et
al29 demonstrated a 50% higher relative mortality risk for
women undergoing either open or endovascular repair in a
multivariate model using the Medicare database.
Last, there has been speculation that performing EVAR
earlier (ie, at a smaller AAA size threshold) will eliminate
some of the aforementioned problems with meeting IFU
criterion. This speculation is based on smaller studies sug-
gesting that AAA anatomy becomes less suitable for EVAR
in larger aneurysms. Our study demonstrates that indeed
larger aneurysms are less likely tomeet the IFU criterion for
EVAR. However, the drop-off in terms of percentage of
patients meeting EVAR criterion occurs at 5.5 cm in
women and 6.5 cm in men. These data expand upon the
findings of a recent non-gender-specific study of 168 pa-
tients proposing a 5.7 cm threshold at which EVAR eligi-
bility decreases.30 Based on the current data, there is a low
likelihood that a patient will lose eligibility for EVAR if his
or her AAA enlarges to the 5.5-cm standard threshold for
repair, especially if using a smaller threshold of 5 cm for
women based on the U.K. Small Aneurysm Trial data.27,28
A study of serial imaging data would be preferable to show
this, but certainly there is no clear justification for repair at
a small size based on the current data or the randomized
Positive Impact of Endovascular Options for treating An-
eurysms Early trial data.31
There are limitations to these data. The dataset does
not include all clinically relevant anatomic features, includ-
ing plaque thickness, calcification, mural thrombus, com-
mon iliac occlusive disease, accessory renal arteries, or iliac
tortuosity. Furthermore, the ultimate determination of
EVAR eligibility is a clinical one based on an experienced
physician’s review of the patient’s condition and preopera-
tive imaging. Anatomic limiters such as neck length and
angulation are evaluated in conjunction with one another
and in the context of the entire AAA anatomy. These
complex anatomic interactions may further reduce the like-
lihood of EVAR eligibility, so these data may overestimate
EVAR eligibility with strict adherence to IFU criterion.
The iliac diameter measurement is a focal point estimate of
the external iliac and is an incomplete descriptor of the
adequacy of iliac access. Furthermore, there is known inter-
observer variability that persists despite highly trained un-
biased observers, although this variability should be similar
for men and women. As a single center study from a
regional referral hospital, the results of this study cannot bextrapolated to all patients with AAA. Future multicenter
rojects with CHAP will hopefully further our understand-
ng of these issues. These data are cross sectional, so infer-
nces made about the relationships between AAA size and
eck anatomy reflect those associations across a large pop-
lation of patients rather the longitudinal behavior of any
ingle AAA.
ONCLUSIONS
Women are less likely to meet IFU criterion for EVAR
han men. Short neck length remains the main limiter of
VAR for both men and women, but future stent graft
esigns accommodating 90 degrees of neck angulation and
tilizing 16F to 18F outer diameter delivery systems will
lso substantially increase on-label use of EVAR, especially
n women. The percentage of patients with AAA that meet
FU criterion diminishes rapidly as the AAA size exceeds
.5 cm in women and 6.5 cm in men, but it seems that
bservation of AAAs up to standard thresholds for repair is
nlikely to change EVAR eligibility substantially.
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